HRT Financial’s Strongbridge Biopharma plc. SBBP Stock Holding History

HRT Financial’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-96,533	Closed	-$196K	–	4530
2021 Q3	$196K	Sell	96,533 -27,582	-22%	-$64.2K	﹤0.01%	2700
2021 Q2	$368K	Buy	+124,115	New	+$328K	﹤0.01%	2012
2020 Q1	–	Sell	-16,788	Closed	-$35K	–	1532
2019 Q4	$35K	Buy	+16,788	New	+$32.2K	﹤0.01%	1085
2019 Q3	–	Sell	-20,422	Closed	-$63K	–	1678
2019 Q2	$63K	Buy	+20,422	New	+$75K	﹤0.01%	690

HRT Financial's SBBP Position: Q4 2021 in Review

HRT Financial sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 96,533 shares — an estimated $196K sold.

HRT Financial first reported a position in SBBP in Q2 2019 and held it in 4 quarters. The position peaked at $368K in Q2 2021. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

HRT Financial reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
HRT Financial sold 96,533 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $196K.
HRT Financial first reported a position in Strongbridge Biopharma plc. in Q2 2019 and held it in 4 quarters.
HRT Financial's Strongbridge Biopharma plc. position peaked at $368K in Q2 2021.
0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on HRT Financial's 13F filing for Q4 2021, filed 14 Feb 2022.